A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma

BACKGROUND: Concurrent treatment with temozolomide and radiotherapy followed by maintenance temozolomide is the standard of care for patients with newly diagnosed glioblastoma. Bevacizumab, a humanized monoclonal antibody against vascular endothelial growth factor A, is currently approved for recurr...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Gilbert, Mark R., Dignam, James J., Armstrong, Terri S., Wefel, Jeffrey S., Blumenthal, Deborah T., Vogelbaum, Michael A., Colman, Howard, Chakravarti, Arnab, Pugh, Stephanie, Won, Minhee, Jeraj, Robert, Brown, Paul D., Jaeckle, Kurt A., Schiff, David, Stieber, Volker W., Brachman, David G., Werner-Wasik, Maria, Tremont-Lukats, Ivo W., Sulman, Erik P., Aldape, Kenneth D., Curran, Walter J., Mehta, Minesh P.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2014
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4201043/
https://ncbi.nlm.nih.gov/pubmed/24552317
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1308573
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak